India allocates LPG for polymer, steel, and pharma sectors to boost industrial output during energy supply challenges....
pharma manufacturing
US considers up to 100% tariffs on brand-name drugs, potentially impacting pharmaceutical investments, costs, and market access....
Biocon expands US portfolio with Bosaya & Aukelso biosimilars, offering affordable treatments for bone conditions. FDA-approved, now...
UPSIDA and JNPA partner to transform Lalitpur Pharma Park into a global export hub, streamlining logistics and...
Indian pharma exports approach $29 billion despite global volatility, highlighting India's role as a key affordable medicine...
Trump's tariff threat on pharma firms sparks debate. Impact on market access, investment strategies, and drug pricing....
US tariffs on patented drugs unlikely to significantly affect India's generic medicine exports. GTRI report highlights limited...
Explore the potential impact of Trump's proposed tariffs on brand-name drugs, focusing on implications for private equity,...
Explore the origins and market impact of Indian pharmaceutical company names. Discover how names reflect history, strategy,...
India's rising trend of using weight-loss drugs like Mounjaro for cosmetic reasons sparks ethical debates and investment...